Oncology & Cancer

Novel form of immunotherapy could revolutionize cancer treatment

A novel form of macrophage-based immunotherapy is effective at treating a broad spectrum of cancers, including those at advanced stages, according to a groundbreaking study led by Georgia State immunology professor Yuan Liu.

Oncology & Cancer

Consumer health: Treating bladder cancer

More than 81,000 new cases of bladder cancer will be diagnosed in the U.S. in 2022, and more than 17,000 people will die of the disease, according to the American Cancer Society.

Medical research

Scientists closer to outsmarting malaria parasites

Researchers from The Australian National University (ANU) have discovered why malaria parasites are vulnerable to some drug therapies but resistant to others, offering scientists another piece of the puzzle in the global ...

Oncology & Cancer

Oncology therapy at the end-of-life: Have we missed the mark?

Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and hospice enrollment, escalates costs, and may adversely affect the quality of care patients receive. Accordingly, over ...

Diseases, Conditions, Syndromes

CAR T cell therapy could reach beyond cancer

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small ...

Oncology & Cancer

Potential cancer therapy may boost immune response

A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according ...

page 3 from 40